Charcot neuro-osteoarthropathy (often called the Charcot foot) is one of the most consequential yet under-recognized complications of diabetes. It is a progressive condition in which inflammation, bone weakening, and joint dislocation occur in a foot that has lost protective sensation. Because the process is frequently painless, it can silently destroy the normal architecture of the foot within weeks. Understanding how it develops, how it is diagnosed, and how it is managed is essential for anyone living with diabetic peripheral neuropathy, as well as the clinicians and caregivers who support them.
Why the Charcot Foot Develops
Charcot neuroarthropathy arises against a background of peripheral neuropathy, in which nerve damage removes the pain signals that normally protect the foot from repetitive injury. As reviewed by Bansod and colleagues, the pathophysiology is multidimensional, combining sensory-motor neuropathy, repetitive trauma, and autonomic dysfunction that increases blood flow to bone and accelerates bone resorption. Poor glycemic control, longer duration of diabetes, and the presence of neuropathy are all recognized contributors to risk. The result is a foot that continues to bear weight even as its bones and joints are being damaged, so ordinary walking becomes the very mechanism of destruction.
The Diagnostic Challenge of the Acute Phase
The greatest danger of the Charcot foot lies in how easily its early, active phase is missed. In this stage the foot is typically warm, red, and swollen, and it is often mistaken for infection, cellulitis, gout, or a simple sprain. The 2023 guidelines from the International Working Group on the Diabetic Foot (IWGDF), led by Wukich and colleagues, emphasize that clinicians should maintain a high index of suspicion whenever a person with neuropathy presents with a warm, swollen foot, even in the absence of pain or a clear injury. A useful clinical clue is a temperature difference between the affected and unaffected foot.
Because early plain radiographs can appear normal, advanced imaging plays a central role. Magnetic resonance imaging is particularly valuable for detecting the bone marrow edema and subtle changes that precede visible collapse, and it helps distinguish Charcot changes from osteomyelitis. Schweitzer and Rockhill note that a delayed diagnosis allows the disease to progress toward severe deformity, ulceration, infection, and ultimately amputation, which is why prompt recognition is so important.
Conservative Management: Offloading and Immobilization
The cornerstone of treatment for the active Charcot foot is mechanical protection. According to Schweitzer and Rockhill, immobilization and non-weight-bearing should begin immediately once the diagnosis is suspected. The total contact cast is widely regarded as the reference standard for offloading, distributing pressure across the foot and limiting the destructive forces of ambulation. Casting continues until the inflammation resolves and the affected bones and joints have consolidated, a process that can take several months and is often monitored by the resolution of warmth and swelling.
Patient education is a critical, and sometimes overlooked, part of this phase. Because the treatment is prolonged and the foot may not hurt, adherence to non-weight-bearing can be difficult. The IWGDF guidelines highlight that setting expectations and supporting the patient through a long immobilization period substantially improves outcomes and reduces the risk of long-term deformity.
When Surgery Becomes Necessary
Most cases of Charcot neuroarthropathy can be managed without surgery, but reconstruction may be required when severe deformity leaves the foot unstable, ulcerated, or impossible to fit safely into footwear. Spingola and colleagues describe how surgical reconstruction demands rigid fixation, careful resection of diseased bone, and precise anatomic alignment, alongside attention to vascular status and infection. Sammarco and colleagues describe the modern “superconstruct” approach, which extends fusion beyond the zone of injury, resects bone to reduce deformity, and uses stronger, load-sharing implants to maximize stability in a compromised foot. These techniques reflect how far surgical care has advanced, though nonsurgical management remains successful in the majority of patients.
Key Takeaways
Charcot neuroarthropathy is a serious but often preventable cause of disability in people with diabetic neuropathy. The most important clinical message is one of vigilance: a warm, swollen foot in a person with neuropathy should be considered an active Charcot foot until proven otherwise. Early diagnosis, aided by clinical suspicion and imaging such as MRI, allows prompt offloading before irreversible deformity develops. Prolonged immobilization and non-weight-bearing remain the foundation of care, with surgery reserved for severe or unstable deformity. Consistent glycemic control, regular foot examination, and patient education underpin both prevention and successful recovery.
References
Wukich DK, Schaper NC, Gooday C, et al. Guidelines on the diagnosis and treatment of active Charcot neuro-osteoarthropathy in persons with diabetes mellitus (IWGDF 2023). Diabetes/Metabolism Research and Reviews. 2023;40(3):e3646.
Schweitzer M, Rockhill S. Conservative Management of Charcot Neuroarthropathy. Clinics in Podiatric Medicine and Surgery. 2022;39(4):585–594.
Bansod H, Wanjari A, Dumbhare O. A Review on the Relationship Between Charcot Neuroarthropathy and Diabetic Patients. Cureus. 2023;15(12):e50988.
Spingola HD, Martucci J, DiDomenico LA. Plate Fixation in Midfoot and Ankle Charcot Neuroarthropathy. Clinics in Podiatric Medicine and Surgery. 2022;39(4):675–693.
Sammarco VJ, Sammarco JA, Baratz ME, Sammarco GJ. Midfoot Fusion Using Superconstructs for the Charcot Foot: Current Techniques and Complications. Instructional Course Lectures. 2024;73:231–245.
Comments
